Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdministrative site changes include addition of Revision v3.4.2 and removal of the funding-status notice and Revision v3.4.1, which do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice about a lapse in government funding and NIH status update has been added, and the page revision has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a glossary toggle, introduces Last Update Submitted that Met QC Criteria and Last Update Posted fields, shows No FEAR Act Data, and updates the revision to v3.4.0, while removing older metadata items such as Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and revision v3.3.4.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing v3.3.3, indicating a minor CMS update with no visible changes to the study content.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check78 days agoChange DetectedThe citation for a related article has been updated to final published details: Oncol Ther. 2025 Dec;13(4):1025-1039, doi: 10.1007/s40487-025-00365-z, with an Epub date of Aug 21, 2025. The previous 'Online ahead of print' designation has been removed.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.